Penn Medicine was recently gifted $10 million, which is being used to establish its new King Center for Lynch Syndrome, writes John George for the Philadelphia Business Journal.
According to Penn Medicine, the new research center is the world’s first named for Lynch syndrome, a genetic condition that increases the risk of developing certain types of cancers.
“The King Center will allow us to attract more scientists and researchers into the Lynch syndrome field,” said Dr. Bryson Katona, the center’s co-founder and inaugural executive director.
It was formed to help advance research, expand education and outreach, and provide comprehensive, lifelong care for patients. The center will also provide researchers with grant funding, resources, and data that will be used to support innovative research.
Lynch syndrome is one of the most common genetic causes of cancer, affecting about 1.2 million Americans.
Over the past six years, Penn Medicine has nearly tripled the number of Lynch syndrome patients it treats to nearly 1,000.
The generous $10 million gift to open the new center was from Cynthia King, the late Jeffery King and Jason and Julie Borrelli. They are longtime supporters of Lynch syndrome research at education at Penn Medicine, driven by personal experiences.
Read more about Penn Medicine’s new King Center for Lynch Syndrome in the Philadelphia Business Journal.
_____
